Stock Scorecard
Stock Summary for Quest Diagnostics Inc (DGX) - $135.42 as of 4/26/2024 3:08:27 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DGX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DGX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DGX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for DGX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for DGX
Financial Details for DGX
Company Overview |
|
|---|---|
| Ticker | DGX |
| Company Name | Quest Diagnostics Inc |
| Country | USA |
| Description | Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-MEDICAL LABORATORIES |
| Most Recent Quarter | 3/31/2024 |
| Next Earnings Date | 5/16/2024 |
Stock Price History |
|
| Last Day Price | 135.42 |
| Last Day Price Updated | 4/26/2024 3:08:27 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | 1,013,022 |
| 52-Week High | 143.16 |
| 52-Week Low | 117.60 |
| Last Price to 52 Week Low | 15.15% |
Valuation Measures |
|
| Trailing PE | 18.51 |
| Industry PE | 265.59 |
| Sector PE | 56.64 |
| 5-Year Average PE | 23.47 |
| Free Cash Flow Ratio | 31.71 |
| Industry Free Cash Flow Ratio | 18.70 |
| Sector Free Cash Flow Ratio | 30.65 |
| Current Ratio Most Recent Quarter | 0.97 |
| Total Cash Per Share | 4.27 |
| Book Value Per Share Most Recent Quarter | 57.95 |
| Price to Book Ratio | 2.26 |
| Industry Price to Book Ratio | 2.74 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 1.54 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.51 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
| Total Shares Outstanding | 111,056,000 |
| Market Capitalization | 15,039,203,520 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/5/2024 |
| Last Dividend Amount | 0.71 |
| Current Dividend Amount | 0.75 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 2.88 |
| Trailing Annual Dividend Yield | 2.13% |
| Forward Annual Dividend Rate | 3.08 |
| Forward Annual Dividend Yield | 2.28% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 1.69% |
| 5-Year Average Dividend Yield | 1.78% |
| 1-Year Dividend Growth Rate Percentage | 7.31% |
| 3-Year Dividend Growth Rate Percentage | 7.37% |
| 5-Year Dividend Growth Rate Percentage | 7.11% |
| All-Time Dividend Growth Rate Percentage | 11.14% |
| Dividend Payout Ratio | 38.76% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -3.40% |
| Annual Earnings Growth | -9.73% |
| Reported EPS 12 Trailing Months | 7.43 |
| Reported EPS Past Year | 2.04 |
| Reported EPS Prior Year | 8.71 |
| Net Income Twelve Trailing Months | 846,000,000 |
| Net Income Past Year | 854,000,000 |
| Net Income Prior Year | 946,000,000 |
| Quarterly Revenue Growth YOY | 1.50% |
| 5-Year Revenue Growth | 3.86% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 474,000,000 |
| Total Cash Past Year | 686,000,000 |
| Total Cash Prior Year | 315,000,000 |
| Net Cash Position Most Recent Quarter | -3,330,000,000 |
| Net Cash Position Past Year | -4,027,000,000 |
| Long Term Debt Past Year | 4,713,000,000 |
| Long Term Debt Prior Year | 3,980,000,000 |
| Total Debt Most Recent Quarter | 3,804,000,000 |
| Equity to Debt Ratio Past Year | 0.57 |
| Equity to Debt Ratio Most Recent Quarter | 0.63 |
| Total Stockholder Equity Past Year | 6,307,000,000 |
| Total Stockholder Equity Prior Year | 5,893,000,000 |
| Total Stockholder Equity Most Recent Quarter | 6,432,000,000 |
Options |
|
| Put/Call Ratio | 0.29 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.35 |
| MACD Signal | 0.71 |
| 20-Day Bollinger Lower Band | 121.08 |
| 20-Day Bollinger Middle Band | 130.14 |
| 20-Day Bollinger Upper Band | 139.20 |
| Beta | 0.89 |
| RSI | 68.07 |
| 50-Day SMA | 130.22 |
| 200-Day SMA | 129.18 |
System |
|
| Modified | 4/26/2024 10:47:33 PM EST |